LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $4,557,516
Key CONT_AWD_75N91025F00024_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 33 days before this system saw it. One version on record.
Cite this row
8bcf76f0c8d985ee92e29d8ba12e6b4083e7b736080a6005fd2a9328a253b053The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $4,557,516 | first version | September 10, 2025 | August 3, 2026 | 2026-09-05T00:55:28Z | historical sweep | 8bcf76f0c8d9 |
Archived copy
https://web.archive.org/web/20261014221156/https://www.usaspending.gov/award/CONT_AWD_75N91025F00024_7529_75N91019D00024_7529 captured by this system, October 14, 2026
What the amount is made of
2 recorded actions, so the amount is the award's current total across all of them. 2 of them obligated money. Measured 2026-10-10, when USAspending reported a total obligation of $4,557,516.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| August 3, 2026 | P00001 | OTHER ADMINISTRATIVE ACTION | +$2,047,008 | DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES |
| September 10, 2025 | base | not on file | +$2,510,508 | DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES |
Last refreshed November 4, 2026 at 2:31 PM UTC.